|
|
||||||||
Ann Thorac Surg 2002;74:1953-1957
© 2002 The Society of Thoracic Surgeons
a Division of Surgery, Clinical Pathology, Toneyama National Hospital, Osaka, Japan
B Division of Surgery, Kinki Central National Hospital for Chest Diseases Osaka, Japan
C Division of General Thoracic Surgery, Department of Surgery (E-1), Osaka University Graduate School of Medicine Osaka, Japan
D Division of Surgery, Habikino Hospital, Osaka, Japan
Accepted for publication June 28, 2002.
* Address reprint requests to Dr Sawabata, Division of Surgery, Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan.
e-mail: nori{at}toneyama.hosp.go.jp
BACKGROUND: We have developed a novel test for the surgical margin of pulmonary malignant tumor using a cytologic technique (the run-across method in which a glass slide is run across the staple site), and we have assessed whether this method is useful in predicting margin relapse and prognosis.
METHODS: From April 1996 to March 1999, 15 lesions of stage I non-small cell lung cancer (NSCLC) (maximum diameter ranged from 10 to 35 mm with a median of 20 mm) from 15 patients with cardiopulmonary impairment were excised without additional proximal resections. The surgical margin was examined using the run-across method. There were 8 male 7 female patients whose ages ranged from 51 to 80 years. One patient underwent video-assisted thoracic surgery and 14 underwent thoracotomy. The preoperative diagnoses of the patients were 13 adenocarcinomas, 2 squamous cell carcinomas, and 1 undiagnosed lesion (1 adenocarcinoma). The follow-up period ranged from 37 to 63 months.
RESULTS: The rate of positive cytology was 47% in comparison with the rate of positive histology of 20%. There were 4 patients with margin relapse (3 of them contained negative histology margins) at a rate of 57% among the positive cytology patients in comparison with 0% among the negative cytology patients (p = 0.03). In a comparison of survival between the negative cytology group and the positive cytology group, there were no statistically significant differences.
CONCLUSIONS: The run-across method is also useful in confirming complete resection. A positive cytology margin could lead to margin relapse even if a non-small cell lung cancer is resected with a negative histology margin.
This article has been cited by other articles:
![]() |
N. Sawabata A segmentectomy for stage IA non small cell lung cancer should be associated with surgical margin cytology findings and a frozen section histologic examination of lymph nodes J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 822 - 822. [Full Text] [PDF] |
||||
![]() |
H. Nomori, K. Ikeda, T. Mori, H. Kobayashi, K. Iwatani, K. Kawanaka, S. Shiraishi, and T. Kobayashi Reply to the Editor J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 822 - 823. [Full Text] [PDF] |
||||
![]() |
A. El-Sherif, H. C. Fernando, R. Santos, B. Pettiford, J. D. Luketich, J. M. Close, and R. J. Landreneau Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer Ann. Surg. Oncol., August 1, 2007; 14(8): 2400 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata Detecting Metastasis of Lung Cancer in Mediastinal Lymph Nodes: The Discrepancy Between Cytology and Histology Ann. Thorac. Surg., April 1, 2006; 81(4): 1547 - 1547. [Full Text] [PDF] |
||||
![]() |
B. D. T. Daly and T. A. DiPetrillo Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases?: Reply Ann. Thorac. Surg., April 1, 2004; 77(4): 1504 - 1504. [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Inoue, S.-i. Takeda, and H. Maeda Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases? Ann. Thorac. Surg., April 1, 2004; 77(4): 1503 - 1504. [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Ohta, A. Matsumura, K. Nakagawa, H. Hirano, H. Maeda, and H. Matsuda Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Ann. Thorac. Surg., February 1, 2004; 77(2): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Higashiyama, K. Kodama, K. Takami, N. Higaki, T. Nakayama, and H. Yokouchi Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse: Reply to the Editor J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 611 - 611. [Full Text] [PDF] |
||||
![]() |
N. Sawabata Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 610 - 611. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |